New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 13, 2014
07:23 EDTTKMR, MONTekmira signs license option agreement with Monsanto
Tekmira Pharmaceuticals (TKMR) announced that it has signed an Option Agreement with Monsanto (MON), pursuant to which Monsanto may obtain a license to use Tekmira's proprietary delivery technology. The transaction will support the application of Tekmira's proprietary delivery technology and related intellectual property for use in agriculture. Tekmira noted that the potential value of the transaction could reach up to $86.2M following the successful completion of milestones. Tekmira expects to receive a near term payment of net $16.5M. Over the option period, which is expected to be approximately four years, Tekmira will provide lipid formulations to Monsanto's research and development activities, and Monsanto will make certain payments to Tekmira to maintain its option rights. At any time during the option period, Monsanto may choose to exercise its option, in which case Monsanto will pay to Tekmira an option exercise fee and will receive a worldwide, exclusive right to use Tekmira's proprietary delivery technology in the field of agriculture. Monsanto may elect to terminate this option at their discretion. Tekmira retains all rights to therapeutics uses of all current IP and IP developed under the agreement. The agreement follows Monsanto's initial testing of Tekmira's proprietary delivery technology and the demonstration of initial positive results from use of that technology in the field of agriculture, the company said.
News For TKMR;MON From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
October 1, 2014
06:19 EDTTKMRTekmira volatility low into CDC confirms first U.S. Ebola case in Texas
Subscribe for More Information
September 30, 2014
18:51 EDTTKMRTekmira surges after hours on first confirmed U.S. Ebola case
Subscribe for More Information
18:36 EDTTKMROn The Fly: After Hours Movers
Subscribe for More Information
17:58 EDTTKMRCDC confirms first U.S. patient diagnosed with Ebola virus
Subscribe for More Information
17:39 EDTTKMRCompanies developing Ebola treatments rise after CDC confirms U.S. Ebola case
Subscribe for More Information
16:44 EDTTKMRTekmira up 12% after hours following CDC confirmation of Ebola case in U.S.
September 28, 2014
19:23 EDTMONThis harvest could be trouble for Deere, Potash, Monsanto, Barron's says
Subscribe for More Information
September 26, 2014
07:47 EDTTKMREMA to review BioCryst, Sarepta, Tekmira experimental Ebola medicines
Subscribe for More Information
06:45 EDTMONMonsanto volatility flat into Q4 and revenue outlook
Subscribe for More Information
September 25, 2014
06:41 EDTTKMRTekmira volatility flat on wide price movement
Subscribe for More Information
September 23, 2014
06:13 EDTTKMRTekmira to collaborate with international consortium researching Ebola
Subscribe for More Information
September 22, 2014
13:02 EDTTKMRTekmira surges on FDA authorization of TKM-Ebola for emergency use
Subscribe for More Information
12:57 EDTTKMRTekmira up 20% following FDA authorization of TKM-Ebola for emergency use
09:16 EDTTKMRTekmira establishes regulatory framework for emergency use of TKM-Ebola
Subscribe for More Information
September 18, 2014
12:44 EDTMONMonsanto optimistic about Intacta sales in Brazil
Subscribe for More Information
12:33 EDTMONMonsanto reiterates target of doubling EPS between now and 2019
Subscribe for More Information
10:00 EDTMONOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:02 EDTMONMonsanto upgraded at Stifel
Subscribe for More Information
06:10 EDTMONMonsanto upgraded to Buy from Hold at Stifel
September 17, 2014
15:02 EDTTKMRCongressman questions why FDA hasn't moved on Ebola drug, The Hill says
Republican Congressman Michael Burgess said he was "bewildered" as to why the FDA continues to have a hold on Tekmira's TKS-Ebloa drug, a treatment for Ebola, according to The Hill. However, Democratic Congresswoman Betty McCollum warned against using Africa as a "testing ground" for drugs that haven't been property screened, the website noted. Reference Link
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use